S’Dravious A. DeVeaux

The paper shows that exogenous sphingomyelinase increases MSC-derived EV yield and alters their cargo, enhancing therapeutic effects in a murine wound model.

This study shows that sphingomyelinase treatment alters lipid and protein metabolites in MSCs, enhancing their immunomodulatory properties similar to cytokine-based priming.

This study shows that neuroinflammation and lipid dysregulation contribute to social stress-induced cognitive deficits in sickle cell disease using a mouse model.